hexamethonium has been researched along with Choroid Neovascularization in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicotine was administered orally in the drinking water to achieve serum levels consistent with those of chronic smokers." | 1.32 | Nicotine increases size and severity of experimental choroidal neovascularization. ( Cousins, SW; Espinosa-Heidmann, DG; Hernandez, EP; Marin-Castano, ME; Pereira-Simon, S; Suñer, IJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suñer, IJ | 1 |
| Espinosa-Heidmann, DG | 1 |
| Marin-Castano, ME | 1 |
| Hernandez, EP | 1 |
| Pereira-Simon, S | 1 |
| Cousins, SW | 1 |
1 other study available for hexamethonium and Choroid Neovascularization
| Article | Year |
|---|---|
Nicotine increases size and severity of experimental choroidal neovascularization.
Topics: Administration, Oral; Animals; Cell Division; Choroid; Choroidal Neovascularization; Disease Models, | 2004 |